Andrew Yuen
Analyst-Equity bij Gordonmd Global Investments LP
Profiel
Mr. Andrew Yuen is a Senior Analyst at Gordonmd Global Investments LP.
Prior to joining, He was an Equity Research Associate for two years at The Capital Group.
Before joining The Capital Group, He was employed by J.P.
Morgan Securities LLC.
He holds a bachelor’s degree in Business Administration, with a concentration in Finance, from the University of Washington.
Actieve functies van Andrew Yuen
| Bedrijven | Functie | Begin |
|---|---|---|
Gordonmd Global Investments LP
 Gordonmd Global Investments LP Investment ManagersFinance Gordonmd Global Investments LP is a private company that combines medical and investing expertise to create a singular advantage for biopharmaceutical investors. The company is based in Beverly Hills, CA. The company is dedicated to sourcing highly differentiated investments through their experience and expertise as investment professionals with distinctive backgrounds in the medical/healthcare/finance space. The company was founded in 2021 by Craig Gordon, MD, a licensed physician, who has been the CEO since 2021. | Analyst-Equity | 01-01-2021 |
Opleiding van Andrew Yuen
| University of Washington | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Gordonmd Global Investments LP
Gordonmd Global Investments LP Investment ManagersFinance Gordonmd Global Investments LP is a private company that combines medical and investing expertise to create a singular advantage for biopharmaceutical investors. The company is based in Beverly Hills, CA. The company is dedicated to sourcing highly differentiated investments through their experience and expertise as investment professionals with distinctive backgrounds in the medical/healthcare/finance space. The company was founded in 2021 by Craig Gordon, MD, a licensed physician, who has been the CEO since 2021. | Finance |
